Medications would be developed to prevent the RASFs from spreading from joint to joint and slow, or even halt, the progression of RA.
James Woods, a microbiologist at Midwestern University in Downers Grove, Illinois suggests that RASFs might be genetically engineered to heal the joints they invade, as opposed to damaging them.